Breast cancer predisposing alleles in Poland

Breast Cancer Research and Treatment

Volumn 92, Issue 1, 2005, Pages 19-24

  Gorski B ^a   Cybulski, C ^a   Huzarski, T ^a   Byrski, T ^a   Gronwald, J ^a   Jakubowska, A ^a   Stawicka, M ^b   Gozdecka Grodecka, S ^c   Szwiec, M ^d   Urbanski K ^e   Mitus J ^e   Marczyk, E ^e   Dziuba, J ^a   Wandzel, P ^f   Surdyka, D ^g   Haus, O ^h   Janiszewska, H ^h   Debniak T ^a   Toloczko Grabarek A ^a   Medrek, K ^a   Masojc B ^a   Mierzejewski, M ^a   Kowalska, E ^a   Narod, S A ⁱ   Lubinski J ^a   more..

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Prophylactic and Epidemiology Center   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d Regional Hospital   (Poland)

^e INSTITUTE OF ONCOLOGY   (Poland)

^f Regional Oncology Hospital   (Poland)

^g Regional Oncology Hospital   (Poland)

^h NICOLAUS COPERNICUS UNIVERSITY   (Poland)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA1; Breast cancer; CHEK2; NBS1

Indexed keywords

BRCA1 PROTEIN; CHECKPOINT KINASE 2;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; POLAND; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CELL CYCLE PROTEINS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; POLAND; PREVALENCE; PROTEIN-SERINE-THREONINE KINASES; RISK; RISK ASSESSMENT;

EID: 21044452905     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-1409-1     Document Type: Article

References (13)

1. B Górski T Byrski T Huzarski A Jakubowska J Menkiszak J Gronwald A Pluzanska M Bebenek L Fischer-Maliszewska E Grzybowska SA Narod J Lubiński 2000 Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer Am J Hum Genet 66 1963 1968
2. B Górski A Jakubowska T Huzarski T Byrski J Gronwald E Grzybowska A Mackiewicz M Stawicka M Bȩbenek D Sorokin Ł Fiszer-Maliszewska O Haus H Janiszewska S Niepsuj S Góźdź L Zaremba M Posmyk M Płużańska E Kilar D Czudowska B Waśko R Miturski JR Kowalczyk K Urbański M Szwiec J Koc A Rozmiarek T Dȩbniak C Cybulski E Kowalska A Tołoczko-Grabarek S Zaja̧czek J Menkiszak K Mȩdrek B Masojć M Mierzejewski S Narod J Lubiński 2004 A high proportion of founder BRCA1 mutations in Polish breast cancer families Int J Cancer 110 683 686
3. G Johannesdottir J Gudmundsson JT Bergthorsson A Arason BA Agnarsson G Eiriksdottir OT Johannsson A, Borg S Ingvarsson DF Easton V Egilsson RB Barkardottir 1996 High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients Cancer Res 56 3663 3665
4. JP Struewing RE Tarone LC Brody FP Li JD Boice Jr. 1996 BRCA1 mutations in young women with breast cancer Lancet 347(9013) 1493
5. The CHEK2 Breast Cancer Consortium: Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC genetic variant contributing to a substantial fraction of familial breast cancer. Nat Genet 31: 55-59, 2002
6. B Gorski T Dȩbniak B Masojc M Mierzejewski M Medrek K Medrek C Cybulski A Jakubowska G Kurzawski M Chosia R Scott J Lubinski 2003 Germline 657del5 mutation in the NBS1 gene in breast cancer patients Int J Cancer 106 379 381
7. K Offit H Pierce T Kirchhoff P Kolachana B Rapaport P Gregerson S Johnson O Yossepowitch H Huang J Satagopan M Robson L Scheuer K Nafa N Ellis 2003 Frequency of CHEK2*1100 delC in New York breast cancer cases and controls BMC Med Genet 4 1
8. C Cybulski T Huzarski B Górski B Masojć M Mierzejewski T Dȩbniak B Gliniewicz J Matyjasik E Złowocka G Kurzawski A Sikorski M Posmyk M Szwiec R Czajka SA Narod J Lubiński 2004 A novel founder CHEK2 mutation is associated with increased prostate cancer risk Cancer Res 64 2677 2679
9. Masojć B, Mierzejewski M, Gorski B: Constitutional Mutations in NBS1 Gene in Patients with Sporadic and Hereditary Cancer of Mammary Gland, Book of Abstracts. International Congress for Students and Young Physicans, Warsaw, Poland, 2001
10. Steffen J, Varon R, Thomas M, Stumm M, Maurer M, Nowakowska D, et al.: The Frequency of Heterozygous Germline Mutation 657del5 in Cancer Patients from Poland. Cs.Lek.Csk. 141,202 C suppl. 8, Book of Abstracts. International Workshop on Nijmegen Breakage Syndrome, Prague, Czech republic, 2002
11. Cybulski C, Górski B, Dȩbniak T, Gliniewicz B, Mierzejewski M, Masojć B, Jakubowska A, Matyjasik A, Złowocka E, Sikorki A, Narod SA, Lubiński J: NBS1 is a prostate cancer susceptibility gene. Cancer Res (in press) 2004
12. J Menkiszak B Górski A Jakubowska T Huzarski T Byrski J Gronwald M Foszczyńska-Kłoda O Haus H Janiszewska M Perkowska I Brożek E Grzybowska H Ziȩtek S Góźdź B Klonowska K Urbański R Miturski J Kowalczyk A Płużańska S Niepsuj J Koc M Szwiec K Drosik A Mackiewicz K Lamperska E Stróżyk D Godlewski M Stawicka B Waśko M Bȩbenek A Rozmiarek I Rzepka-Górska SA Narod J Lubiński 2003 Hereditary ovarian cancer in Poland Int J Cancer 106 942 945
13. Thompson D, Easton D, the Breast Cancer Linkage Consortium: variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 11: 329-336, 2002